Literature DB >> 16391915

Late angiographic and clinical follow-up results of 100 consecutive aneurysms treated with Onyx reconstruction: largest single-center experience.

H Saruhan Cekirge1, Isil Saatci, M Halil Ozturk, Barbaros Cil, Anil Arat, Michel Mawad, Fikret Ergungor, Deniz Belen, Uygur Er, Sami Turk, Murat Bavbek, Zeki Sekerci, Ethem Beskonakli, Osman E Ozcan, Tuncalp Ozgen.   

Abstract

We present the long-term clinical and angiographic follow-up results of 100 consecutive intracranial aneurysms treated with Onyx liquid embolic system (MTI, Irvine, Calif.), either alone or combined with an adjunctive stent, in a single center. A total of 100 aneurysms in 94 patients were treated with endosaccular Onyx packing. Intracranial stenting was used adjunctively in 25 aneurysms including 19 during initial treatment and 6 during retreatment. All aneurysms except two were located in the internal carotid artery. Of the 100 aneurysms, 35 were giant or large/wide-necked, and 65 were small. Follow-up angiography was performed in all 91 surviving patients (96 aneurysms) at 3 and/or 6 months. Follow-up angiography was performed at 1, 2, 3, 4 and 5 years in 90, 41, 26, 6 and 2 patients, respectively. Overall, aneurysm recanalization was observed in 12 of 96 aneurysms with follow-up angiography (12.5%). All 12 were large or giant aneurysms, resulting in a 36% recanalization rate in the large and giant aneurysm group. One aneurysm out of 25 treated with the combination of a stent and Onyx showed recanalization. There was also no recanalization in the follow-up of small internal carotid artery aneurysms treated with balloon assistance only. At final follow-up, procedure- or device-related permanent neurological morbidity was present in eight patients (8.3%). There were two procedure-related and one disease-related (subarachnoid hemorrhage) deaths (mortality 3.2%). Delayed spontaneous asymptomatic occlusion of the parent vessel occurred in two patients, detected on routine follow-up. Onyx provides durable aneurysm occlusion with parent artery reconstruction resulting in perfectly stable 1-year to 5-year follow-up angiography both in small aneurysms treated with balloon assistance only (0% recanalization rate) and large or giant aneurysms treated with stent and Onyx combination (4% recanalization rate). Endosaccular Onyx packing with balloon assistance may not be adequate for stable long-term results in those with a large or giant aneurysm. However, the recanalization rate of 36% in these aneurysms is better than the reported results with other techniques, i.e., coils with or without adjunctive bare stents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16391915     DOI: 10.1007/s00234-005-0007-6

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  14 in total

1.  Unruptured intracranial aneurysms--risk of rupture and risks of surgical intervention.

Authors: 
Journal:  N Engl J Med       Date:  1998-12-10       Impact factor: 91.245

2.  A contribution to the controversy over dimethyl sulfoxide toxicity: anesthesia monitoring results in patients treated with Onyx embolization for intracranial aneurysms.

Authors:  A G Pamuk; I Saatci; H S Cekirge; U Aypar
Journal:  Neuroradiology       Date:  2005-05-03       Impact factor: 2.804

3.  Coiling of very large or giant cerebral aneurysms: long-term clinical and serial angiographic results.

Authors:  Menno Sluzewski; Tomas Menovsky; Willem Jan van Rooij; Douwe Wijnalda
Journal:  AJNR Am J Neuroradiol       Date:  2003-02       Impact factor: 3.825

4.  Endovascular treatment of experimental aneurysms by use of a combination of liquid embolic agents and protective devices.

Authors:  Y Murayama; F Viñuela; S Tateshima; F Viñuela; Y Akiba
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

5.  Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms.

Authors:  David Fiorella; Felipe C Albuquerque; Patrick Han; Cameron G McDougall
Journal:  Neurosurgery       Date:  2004-01       Impact factor: 4.654

6.  Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment.

Authors:  David O Wiebers; J P Whisnant; J Huston; I Meissner; R D Brown; D G Piepgras; G S Forbes; K Thielen; D Nichols; W M O'Fallon; J Peacock; L Jaeger; N F Kassell; G L Kongable-Beckman; J C Torner
Journal:  Lancet       Date:  2003-07-12       Impact factor: 79.321

7.  Percutaneous intracranial stent placement for aneurysms.

Authors:  Patrick P Han; Felipe C Albuquerque; Francisco A Ponce; Christopher I MacKay; Joseph M Zabramski; Robert F Spetzler; Cameron G McDougall
Journal:  J Neurosurg       Date:  2003-07       Impact factor: 5.115

8.  Cerebral Aneurysm Multicenter European Onyx (CAMEO) trial: results of a prospective observational study in 20 European centers.

Authors:  Andrew J Molyneux; Saruhan Cekirge; Isil Saatci; Gyula Gál
Journal:  AJNR Am J Neuroradiol       Date:  2004-01       Impact factor: 3.825

9.  Guglielmi detachable coil embolization of cerebral aneurysms: 11 years' experience.

Authors:  Yuichi Murayama; Yih Lin Nien; Gary Duckwiler; Y Pierre Gobin; Reza Jahan; John Frazee; Neil Martin; Fernando Viñuela
Journal:  J Neurosurg       Date:  2003-05       Impact factor: 5.115

10.  Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils.

Authors:  Ronald P Benitez; Marco T Silva; Jack Klem; Erol Veznedaroglu; Robert H Rosenwasser
Journal:  Neurosurgery       Date:  2004-06       Impact factor: 4.654

View more
  22 in total

1.  Current status and future prospect of endovascular neurosurgery.

Authors:  Young Il Jeon; Do Hoon Kwon
Journal:  J Korean Neurosurg Soc       Date:  2008-02-20

2.  MR Coagulation: A Novel Minimally Invasive Approach to Aneurysm Repair.

Authors:  Ouri Cohen; Ming Zhao; Erez Nevo; Jerome L Ackerman
Journal:  J Vasc Interv Radiol       Date:  2017-08-09       Impact factor: 3.464

3.  Endovascular treatment of the distal internal carotid artery large aneurysm.

Authors:  Hong-Ju Bae; Do-Sung Yoo; Pil-Woo Huh; Tae-Gyu Lee; Kyoung-Suok Cho; Sang-Bok Lee
Journal:  J Cerebrovasc Endovasc Neurosurg       Date:  2014-09-30

4.  Embolization of intracranial aneurysms with HydroSoft coils: results of the Korean multicenter study.

Authors:  J H Park; H-S Kang; M H Han; P Jeon; D-S Yoo; T H Lee
Journal:  AJNR Am J Neuroradiol       Date:  2011-09-15       Impact factor: 3.825

5.  Treatment of intracranial aneurysms using the pipeline flow-diverter embolization device: a single-center experience with long-term follow-up results.

Authors:  I Saatci; K Yavuz; C Ozer; S Geyik; H S Cekirge
Journal:  AJNR Am J Neuroradiol       Date:  2012-07-19       Impact factor: 3.825

6.  The "temporary caging" technique for catheter navigation in patients with intracranial wide-necked aneurysms.

Authors:  Hidemichi Ito; Hidetaka Onodera; Daisuke Wakui; Masashi Uchida; Taigen Sase; Hiroyuki Morishima; Kotaro Oshio; Yuichiro Tanaka
Journal:  Int J Clin Exp Med       Date:  2015-07-15

7.  Spinal Dural Arteriovenous Fistula: Imaging Features and Its Mimics.

Authors:  Ying Jeng; David Yen-Ting Chen; Hui-Ling Hsu; Yen-Lin Huang; Chi-Jen Chen; Ying-Chi Tseng
Journal:  Korean J Radiol       Date:  2015-08-21       Impact factor: 3.500

8.  Temporary Balloon Occlusion during Giant Aneurysm Surgery. A Technical Description.

Authors:  B Petralia; M Skrap
Journal:  Interv Neuroradiol       Date:  2006-12-13       Impact factor: 1.610

9.  Solvent stimulated actuation of polyurethane-based shape memory polymer foams using dimethyl sulfoxide and ethanol.

Authors:  A J Boyle; A C Weems; S M Hasan; L D Nash; M B B Monroe; D J Maitland
Journal:  Smart Mater Struct       Date:  2016-05-24       Impact factor: 3.585

10.  Endovascular treatment of intracranial aneurysms with bioactive Cerecyte coils: effects on treatment stability.

Authors:  Serdar Geyik; Kivilcim Yavuz; Onur Ergun; Osman Koc; Saruhan Cekirge; Isil Saatci
Journal:  Neuroradiology       Date:  2008-05-16       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.